NEW MJ NEWS

Sundial to Participate in 2020 Cowen Boston Cannabis Conference

Sundial Growers Inc. (Nasdaq: SNDL) (“Sundial”) today announced that it will participate in Cowen’s 2020 Boston Cannabis Conference, to be held virtually between November 30 and December 2, 2020.

Zach George, CEO of Sundial, will be participating in a panel discussion at 10:10 a.m. EST on December 2, 2020.

ABOUT SUNDIAL GROWERS INC.

Sundial is a public company with Common Shares traded on Nasdaq under the symbol “SNDL”.

Sundial is a licensed producer that crafts cannabis using state-of-the-art indoor facilities. Our ‘craft-at-scale’ modular growing approach, award-winning genetics and experienced growers set us apart.

Our Canadian operations cultivate small-batch cannabis using an individualized “room” approach, with 470,000 square feet of total space.

Sundial’s brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Our consumer-packaged goods experience enables us to not just grow quality cannabis, but also to create exceptional consumer and customer experiences.

We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds, AB, and Rocky View County, AB.

Cision
Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/sundial-to-participate-in-2020-cowen-boston-cannabis-conference-301178835.html

SOURCE Sundial Growers Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$ATTBF Baby Boomers Spend Billions to Stay Young

Baby Boomers Spend Billions to Stay Young Abattis Bioceuticals Signs $25 Million…

$BLPG To Provide Industry Training Standards in Regards to New Cannabis Legalization

Blue Line Protection Group Responds to New Cannabis Legalization With Industry Training…

 The Alkaline Water Company Inc. (WTER) Gain Share in the Fast-Growing Flavored Water Market

A88 Infused™ Flavors Gain Share in the Fast-Growing Flavored Water Market The…

Tilray Brands, Inc. (TLRY) Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment

Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma…